nVerses Capital’s Transcat TRNS Stock Holding History

nVerses Capital’s Portfolio TRNS Stock Details TRNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-500	Closed	-$60.4K	–	825
2024 Q3	$60.4K	Buy	+500	New	+$62.1K	0.03%	583

Other funds holding TRNS

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BAM

Broadcrest Asset Management Winter Park, Florida $44.1M AUM 4.51% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

nVerses Capital's TRNS Position: Q4 2024 in Review

nVerses Capital sold out of Transcat (TRNS) in Q4 2024, closing a stake of 500 shares — an estimated $60.4K sold.

nVerses Capital first reported a position in TRNS in Q3 2024 and held it in 1 quarter. The position peaked at $60.4K in Q3 2024. 137 funds tracked by Wall St. Rank hold TRNS as of Q4 2024.

nVerses Capital reported no remaining Transcat position as of Q4 2024 after selling out during the quarter.
nVerses Capital sold 500 Transcat shares in Q4 2024, an estimated $60.4K.
nVerses Capital first reported a position in Transcat in Q3 2024 and held it in 1 quarter.
nVerses Capital's Transcat position peaked at $60.4K in Q3 2024.
137 funds tracked by Wall St. Rank held Transcat as of Q4 2024.

Based on nVerses Capital's 13F filing for Q4 2024.